In 2018, the analysis of melanoma fecal microbiome samples from 112 patients showed significantly higher alpha diversity and relative abundance of Ruminococcaceae bacteria in responding patients treated with anti-PD-1 immunotherapy [92]. This evidence concerns the gene PDCD1 and melanoma.